Kun Meng

Title: Kun Meng - Innovator in Estrogen Receptor-Related Treatments

Introduction

Kun Meng is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of estrogen receptor-related diseases. His innovative work has the potential to impact the lives of many individuals suffering from various health conditions.

Latest Patents

Kun Meng holds a patent for "Compounds and methods for treating estrogen receptor-related diseases." This patent includes compounds, pharmaceutical compositions, and methods for modulating the functions of estrogen receptor alpha 36. The inventions aim to prevent and treat diseases related to estrogen receptor alpha 36, respiratory diseases such as asthma, and conditions involving abnormal cell proliferation, including cancers. He has 1 patent to his name.

Career Highlights

Kun Meng is associated with Shenogen Pharma Group Ltd., where he applies his expertise in pharmaceutical research and development. His work focuses on creating effective treatments that address critical health issues related to estrogen receptors.

Collaborations

Kun Meng collaborates with Jin Li, a fellow researcher, to advance their shared goals in the pharmaceutical industry. Their partnership enhances the potential for innovative solutions in treating complex diseases.

Conclusion

Kun Meng's contributions to the field of medicine through his patent and work at Shenogen Pharma Group Ltd. highlight his dedication to improving health outcomes. His innovative approaches to treating estrogen receptor-related diseases are paving the way for future advancements in the pharmaceutical industry.